Blog
The Rise and Fall of Tome Biosciences
Tome Biosciences launched in December 2023 with an ambitious goal:...
We developed a Minimum Viable Product (MVP) for a biotech platform company focused on autoimmune disease...
Client Background
A cancer therapeutics company approached us with the need to manage vast amounts of...
In this case study, we explore our partnership with a biotech firm dedicated to advancing liver fibrosis...
In the field of neurobiology, understanding the complex organization and functioning of the brain is...
Clinical trials play a crucial role in the development and evaluation of new drugs and therapies. These...
The study of the microbiome, the complex community of microorganisms that inhabit our bodies and the...
In this drug news post, we will be covering a range of innovative products and therapies that are making...
The human body is home to trillions of microorganisms, collectively known as the microbiome. These microorganisms...
In recent years, ChIP-seq (Chromatin Immunoprecipitation Sequencing) has emerged as a powerful tool in...
Autoimmune diseases are a complex and challenging group of disorders that affect millions of people worldwide....
No posts found